1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
EpiCast Report: Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024

EpiCast Report: Clostridium Difficile Infection (CDI) - Epidemiology Forecast to 2024

  • October 2015
  • 60 pages
  • ID: 3389021
In this report:
Furthermore, the ##-day all-cause mortality in CDI was reported to vary from ##-##%, while the ##-day attributable mortality varied from ##.##% to ##.##% (Mitchell and Gardner, 2012).
In the ##MM and the ##EU, the ≥## year age group constituted ##.##% and ##.##% of the overall diagnosed incident cases of CDI in 2014, respectively.

Summary

Table of Contents

Search Inside

EpiCast Report: Clostridium Difficile Infection - Epidemiology Forecast to 2024

Brief

Clostridium difficile infections are primarily transmitted through the fecal-oral route. There are two main sources of CDI: healthcare-associated CDI and community-associated CDI. The typical clinical symptoms of CDI range from watery diarrhea, anorexia, and nausea, to hypoalbuminemia and abdominal tenderness in severe cases. Though suspected in all patients with antibiotic-associated diarrhea, the confirmatory diagnosis of CDI is primarily based on the combination of clinical features exhibited by the patient and the results of different laboratory tests including stool tests, as well as, in certain rare scenarios, endoscopy or radiologic tests. Recurrence and complications of CDI usually pose grave challenges for the treatment and management of this condition and occur in about 20 - 30.0 percent of the patients treated successfully for their first episode.

GlobalData epidemiologists predict that the diagnosed incident cases of all-CDI will grow from 686,540 cases in 2014 to 825,021 cases in 2024, at an Annual Growth Rate of ~2.0 percent over the 10-year forecast period. Throughout the forecast period, the U.S. will have the more important number of diagnosed incident cases of all-CDI in the 7MM.

This industry report offers an overview of the risk factors, comorbidities, and the overall and historical trends for CDI in the seven main markets (7MM) (US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, and Japan (JP)). It includes a 10-year epidemiological forecast for the diagnosed incident cases of all-CDI split by sex and by age (in 5-year age groups beginning at 18 years and ending at =85 years). The term all-CDI is defined as any instance of suspected CDI and diarrhea, with stool samples testing positive for toxin A, B, or both (enzyme immunoassay [EIA], cytotoxicity test, or polymerase chain reaction [PCR]) or revealing the presence of toxin-producing C. difficile, and includes both HA-CDI and CA-CDI. The analysis also provides the 10-year epidemiology forecast for the all-CDI cases divided by epidemiological association into HA-CDI and CA-CDI. On top of, The study offers a 10-year epidemiological forecast for the recurrent all-CDI cases with a farther segmentation by number of recurrences.

Overview

- The Clostridium difficile infection EpiCast Report offers an overview of the risk factors, comorbidities, and overall trends for CDI in the seven main markets (7MM) (US, France (FR), Germany (DE), Italy (IT), Spain (ES), UK, and Japan (JP)). It includes a 10-year epidemiological forecast for the diagnosed incident cases of all-CDI broken down by sex and by age (in 5-year age groups beginning at 18 years and ending at =85 years).

- The CDI epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is detailed, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Great reasons to purchase

The Clostridium Difficile Infection EpiCast series will allow you to -

- Develop strategic management by understanding the trends shaping and driving the overall CDI market.

- Quantify patient populations in the overall CDI market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for CDI therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Hysteroscopy Instruments Market by Product, Resectoscope, Usability, Application, End User - Global Forecast to 2022

Hysteroscopy Instruments Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • October 2017
  • by MarketsandMarkets

“Global hysteroscopy instruments market projected to grow at a CAGR of 7.8%”The hysteroscopy instruments market is expected to reach USD 1.89 billion by 2022 from USD 1.30 billion in 2017, at a CAGR ...

Atherectomy Devices Market by Product, Application, End User - Global Forecasts To 2022

Atherectomy Devices Market: Global Forecasts until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

The atherectomy devices market projected to grow at a CAGR of 6.1%The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. ...

Blood Warmer Devices/Sample Warmer Market by Sample, End User, Region - Global Forecast to 2022

Blood Warmer Devices/Sample Warmer Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

Global blood warmer devices market projected to grow at a CAGR of 8.4% during the forecast periodThe blood warmer devices market is expected to reach USD 225.6 million by 2022 from USD 150.4 million in ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.